Lipid formulated compositions and methods for inhibiting expression of EG5 and VEGF genes
This invention relates to compositions containing double- stranded ribonucleic acid (dsRNA) in a liquid particle formulation, methods of using the compositions to inhibit the expression of the Eg5/KSPand VEGF, and methods of using the compositions to treat pathological processes mediated by Eg5/KSP...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to compositions containing double- stranded ribonucleic acid (dsRNA) in a liquid particle formulation, methods of using the compositions to inhibit the expression of the Eg5/KSPand VEGF, and methods of using the compositions to treat pathological processes mediated by Eg5/KSP and VEGF expression, such as endometrial cancer.
本发明涉及在液体颗粒制剂中含有双链核糖核酸(dsRNA)的组合物,利用该组合物抑制Eg5/KSP和VEGF的表达的方法,以及利用该组合物治疗由Eg5/KSP和VEGF表达介导的病理过程例如子宫内膜癌的方法。 |
---|---|
Bibliography: | Application Number: CN201910354127 |